PAMT:NASDAQPAMT CORP Analysis
Data as of 2026-09-03 - not real-time
$12.59
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind PAMT CORP is neutral at $12.59, with no clear ordering between short and long averages. The last 30 days have lost 17.0%. Momentum indicators put RSI at 46.0 (neutral) with MACD reading bullish. Price has been bracketed by support at $11.05 and resistance at $15.55.
Revenue is growing at 8.9% on a -7.1% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 82.7%, a beta of 1.07 and a maximum drawdown of 43.5%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Revenue is growing at 8.9% on a -7.1% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 82.7%, a beta of 1.07 and a maximum drawdown of 43.5%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
PAMT's Q2 loss per share narrows year over year, while revenues rise 8.Yahoo Finance29dPamt Corp. books another net loss, 110.6% adjusted TL ORThe above button links to Coinbase. Yahoo...Seeking Alpha16dPAMT CORP's Troubles Aren't Over YetBack in early February, I made the difficult decision to downgrade...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 11.65
- MACD momentum is positive
- 30-day price change of -17.0%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 11.65
- 30-day volatility of 82.7%
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -7.1%
- Negative return on equity of -18.9%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth8.90%
Profit Margin-7.07%
ROE-18.88%
ROA-7.09%
Debt/Equity167.23
P/B Ratio1.3
Op. Cash Flow$-16580000
Free Cash Flow$-28455250
Industry P/E28.6
Technical Analysis
TrendNeutral
RSI46.0
Support$11.05
Resistance$15.55
MA 20$12.63
MA 50$14.04
MA 200$11.65
MACDBullish
VolumeStable
Fear & Greed Index93.88
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta1.07
Volatility82.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.